Skip to main contentSkip to navigation
Sirius Investors
GeneDx Holdings Corp.

GeneDx Holdings Corp.

WGS
NASDAQHealthcare

Revenue Analysis - WGS

Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.

WGS Corporation

Annual

Revenue by Product Line

Latest quarterly revenue breakdown by product segments

Quarterly Product Revenue

Product Revenue Details

Detailed breakdown of revenue by product line

Diagnostic Test

0.0% of total revenue

$101.3M

Diagnostic Test, Third Party Insurance

0.0% of total revenue

$84.9M

Diagnostic Test, Institutional Customers

0.0% of total revenue

$16.1M

Product and Service, Other

0.0% of total revenue

$955.0K

Diagnostic Test, Self Pay

0.0% of total revenue

$286.0K

Historical Revenue Data

Quarterly product revenue breakdown over time (Last 6 records)

Date
Diagnostic Test
Diagnostic Test, Institutional Customers
Diagnostic Test, Self Pay
Diagnostic Test, Third Party Insurance
Product and Service, Other
3/31/2026$101.3M$16.1M$286.0K$84.9M$955.0K
12/31/2025$117.6M$16.2M$297.0K$101.1M$3.4M
9/30/2025$113.5M$17.9M$629.0K$95.0M$3.2M
6/30/2025$99.8M$18.4M$339.0K$81.1M$2.9M
3/31/2025$85.8M$17.6M$96.0K$68.1M$1.4M
12/31/2024$155.3M$31.0M$1.2M$123.1M$2.8M

Revenue Trend Analysis

Analysis of major growing and declining segments based on recent revenue data

Product Segments

Declining Segments
Product and Service, Other-72.1%
Diagnostic Test, Third Party Insurance-16.0%
Diagnostic Test-13.8%

Earnings Reports

Want to see how WGS's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.

View Earnings Reports